Non-operative Treatment Versus Volar Locking Plate in Treatment of Distal Radius Fracture in Patients Over 65 Years

April 26, 2025 updated by: Antti Launonen, Tampere University Hospital

Non-operative Treatment Versus Surgery With Volar Locking Plate in Treatment of Distal Radius Fracture in 65-year-old and Older Patients - a Prospective, Randomized Controlled Trial

The present collaboration study on the treatment of distal radius fractures is aimed to:

(i) to compare non-operative treatment to volar plating in the treatment of initially malaligned distal radius fractures in patients aged 65 and older in terms of functional outcome measured with PRWE

(ii) to compare non-operative treatment to volar plating in the treatment of distal radius fractures with early instability during follow-up, i.e., loss of reduction at 1 week (range 5 to 10 days) in patients aged 65 and older in terms of functional outcome measured with PRWE

(iii)to compare pain, disability, quality of life, grip strength, and the number of complications after non-operative treatment and the initial and delayed operative treatment of distal radius fracture

(iv) to assess the effect of pain catastrophizing score (PCS) on the functional outcome of non-operatively and operatively treated distal radius fracture

(v) to assess the association between physical activity and the number of wrist movements measured with Axivity accelerometer and functional outcome measured with PROMs of non-operatively and operatively treated distal radius fractures

(vi) to assess the effect of initial as well as the final radiological parameters on the functional outcome

(vii) to assess the correlation of probability of radiological malalignment estimated by clinical prediction rule (EWC) with functional outcome measured with PRWE and PASS

Study Overview

Study Type

Interventional

Enrollment (Actual)

291

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Viborg, Denmark
        • Viborg Regional Hospital
      • Jyväskylä, Finland
        • Jyväskylä Central Hospital
      • Pori, Finland
        • Pori Central Hospital
      • Tampere, Finland, 33820
        • Tampere University Hospital
      • Stockholm, Sweden
        • Karolinska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • low energy intra or extra-articular dorsally displaced distal radius fracture within 3 cm of the radiocarpal joint, diagnosed with lateral and posterior-anterior radiographs in ER
  • >10° dorsal tilt and/or over 2 mm step-off and/or over 3 mm shortening in the radiograph

Exclusion Criteria:

  • Refuse to participate the study
  • Open fracture more than Gustilo 1 gradus
  • Age under 65 years
  • Chauffeure's or Barton´s fracture
  • Smith´s fracture (volar angulation of the fracture)
  • Does not understand written and spoken guidance in local languages
  • Pathological fracture or previous fracture in the same wrist or forearm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Cohort 1

Early ustable fracture:

Phase 1:

After closed reduction, if satisfactory reduction is not achieved fulfilling the inclusion criteria, the patient is allocated to Cohort 1. The patient is randomized to either non-operative (=Arm 1) or operative treatment (=Arm 2). Patients allocated to non-operative treatment will undergo a standard treatment protocol. Patients allocated to operative treatment will undergo a surgery with volar locking plate with modified Henry's volar approach.

conservative treatment with 5 weeks cast immobilization
surgery with volar locking plate with modified Henry's volar approach
Other: Cohort 2

Early stable fracture:

Phase 1:

After closed reduction, if satisfactory position is achieved, the patient is allocated to Cohort 2 and conservative treatment is performed as usually.

Phase 2:

Patients allocated to Cohort 2, will visit orthopedic outpatient clinic in 1 week in the hospital where the treatment was initially started. If reduction is maintained the patient will undergo standard follow-up visits. If reduction is lost to fulfill the inclusion criteria for surgery the patient is asked to participate to phase 2 of this study. After the patient´s enrollment has been confirmed and informed consent is signed, the patient is randomized to either non-operative (=Arm 3N) or operative treatment (=Arm 3O). If allocated to non-operative treatment patient will undergo the same protocol as those in the Arm 1. Patients allocated to operative treatment will undergo surgery with volar locking plate with standard volar approach.

conservative treatment with 5 weeks cast immobilization
surgery with volar locking plate with modified Henry's volar approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change over time in Patient Rated Wrist Evaluation (PRWE)
Time Frame: 3 months, 1 year, 2 years

PRWE is the primary outcome measure of wrist pain and disability in the study.

The PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists three subscales: Pain, Function and Cosmetics.

3 months, 1 year, 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability of the wrist measured with the Disability of the Arm, Shoulder and Hand (QuickDASH) questionnaire
Time Frame: 3 months, 1 year, 2 years
The QuickDASH is self-reported questionnaire and shortened version of DASH outcome measure to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb in 11 dimensions in 1-5 scale.
3 months, 1 year, 2 years
Quality of life measured with the 15-D
Time Frame: Baseline, 3 months, 1 year, 2 years
The 15D is a validated, generic, self-administered instrument for assessing the health related quality of life among adults. It combines the advantages of a preference-based and single index measure on a 0-1 scale.
Baseline, 3 months, 1 year, 2 years
Pain measured in Visual Analogue Scale (VAS)
Time Frame: 3 months, 1 year, 2 years
The VAS is derived by health care professional question of pain in scale 0 to 10 in which 0 implies no pain and 10 the worst possible pain.
3 months, 1 year, 2 years
Grip strength measured with a dynamometer
Time Frame: 3 months, 1 year
Grip strength is measured with a dynamometer in kg as the mean of three measurements. It will be numbered in percentage of the uninjured side.
3 months, 1 year
Pain catastrophizing measured with the pain catastrophizing scale (PCS)
Time Frame: baseline, 3 months, 1 year, 2 years
The pain catastrophizing scale (PCS) is measured with a self-administered questionnaire. The PCS is designed to measure person's willingness to catastrophize the pain while they are experiencing it. In the questionnaire patients answer questions about how they feel and think when they are in pain and it can be taken while they are not experiencing pain.
baseline, 3 months, 1 year, 2 years
Physical activity measured with Axivity accelerometer
Time Frame: 3 months, 1 year
Physical activity will be measured in a subgroup of patients in two separate follow-up time points.
3 months, 1 year
Self-assessment
Time Frame: Baseline, 1 year, 2 years
Patient's self-assessment questionnaire will be analyzed to find out which parameters are of most importance for the patient.
Baseline, 1 year, 2 years
EWC
Time Frame: Baseline
Edinbourgh wrist calculator will be used to estimate the propability of loss of reduction during the follow-up.
Baseline
Frailty
Time Frame: Baseline
Clinical Frailty Score
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ville Mattila, Prof, Tampere University Hospital
  • Principal Investigator: Antti Launonen, MD, Tampere University Hospital
  • Study Chair: Minna Laitinen, adjunct prof, Tampere University Hospital
  • Study Chair: Aleksi Reito, MD, Central Finland Central Hospital
  • Study Chair: Juha Kukkonen, MD, Satakunta Central Hospital
  • Study Chair: Teemu Hevonkorpi, MD, Tampere University Hospital
  • Study Chair: Lauri Raittio, MD, Tampere University Hospital
  • Study Chair: Toni Luokkala, MD, Central Finland Central Hospital
  • Study Chair: Li Felländer-Tsai, MD, Karolinska University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2018

Primary Completion (Actual)

June 6, 2023

Study Completion (Actual)

June 6, 2023

Study Registration Dates

First Submitted

August 17, 2016

First Submitted That Met QC Criteria

August 22, 2016

First Posted (Estimated)

August 26, 2016

Study Record Updates

Last Update Posted (Actual)

April 30, 2025

Last Update Submitted That Met QC Criteria

April 26, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Distal Radius Fracture

Clinical Trials on non-operative treatment

Subscribe